| Literature DB >> 12224523 |
A M Friedlander1, S L Welkos, B E Ivins.
Abstract
The only impetus for the development of new anthrax vaccines is to protect humans against the intentional use of Bacillus anthracis as a bioterrorist or warfare agent. Live attenuated vaccines against anthrax in domesticated animals were among the very first vaccines developed. This was followed by the development of nonliving component vaccines leading to the eventual licensure of protein-based vaccines for human use in the 1970s. This chapter will review the recent advances in developing protein, live attenuated, and genetic vaccines against anthrax.Entities:
Mesh：
Substances：
Year: 2002 PMID： 12224523 DOI： 10.1007/978-3-662-05767-4_3
Source DB: PubMed Journal: Curr Top Microbiol Immunol ISSN： 0070-217X Impact factor: 4.291